Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat
Year: 2006
Type: article
Institutions: Royal London Hospital, Eli Lilly (United States)
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2029290656
